Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Lung Cancer

Free Subscription 12.11.2018 1 AJR Am J Roentgenol 1 Ann Surg 1 Ann Thorac Surg 5 Anticancer Res 2 BMC Cancer 1 Br J Cancer 2 Cancer Lett 3 Cancer Res 2 Cancer Sci 1 Chest 2 Clin Lung Cancer 1 Clin Nucl Med 1 Hum Pathol 1 Int J Cancer 1 Int J Radiat Oncol Biol Phys 1 J Cancer Res Clin Oncol 1 J Nucl Med 3 J Surg Oncol 2 J Thorac Cardiovasc Surg 5 J Thorac Oncol 1 Lancet Oncol 1 N Engl J Med 1 Nat Med 1 Oncol Rep 4 PLoS One 1 Proc Natl Acad Sci U S A 2 Semin Oncol 2 Thorax

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

AJR Am J Roentgenol

1. LO SB, Freedman MT, Gillis LB, White CS, et al
   JOURNAL CLUB: Computer-Aided Detection of Lung Nodules on CT With a Computerized Pulmonary Vessel Suppressed Function.
   AJR Am J Roentgenol. 2018 Jan 16:1-8. doi: 10.2214/AJR.17.18718.
   PubMed     Text format     Abstract available
   
   

   
   Ann Surg

2. YANG CJ, Kumar A, Berry MF, D'Amico TA, et al
   Response to: "Comment on: A National Analysis of Longterm Survival Following Thoracoscopic Versus Open Lobectomy for Stage I Nonsmallcell Lung Cancer".
   Ann Surg. 2018 Nov 6. doi: 10.1097/SLA.0000000000003081.
   PubMed     Text format    
   
   

   
   Ann Thorac Surg

3. AHMAD U, Hakim AH, Tang A, Tong MZ, et al
   Patterns of Recurrence and Overall Survival in Incidental Lung Cancer in Explanted Lungs.
   Ann Thorac Surg. 2018 Oct 31. pii: S0003-4975(18)31537.
   PubMed     Text format     Abstract available
   
   

   
   Anticancer Res

4. PHIBOONCHAIYANAN PP, Petpiroon N, Sritularak B, Chanvorachote P, et al
   Phoyunnanin E Induces Apoptosis of Non-small Cell Lung Cancer Cells via p53 Activation and Down-regulation of Survivin.
   Anticancer Res. 2018;38:6281-6290.
   PubMed     Text format     Abstract available
   
   
5. LIU KH, Tsai YT, Chin SY, Lee WR, et al
   Hypoxia Stimulates the Epithelial-to-Mesenchymal Transition in Lung Cancer Cells Through Accumulation of Nuclear beta-Catenin.
   Anticancer Res. 2018;38:6299-6308.
   PubMed     Text format     Abstract available
   
   
6. MOENG S, Seo HA, Hwang CY, Cipolla GA, et al
   MicroRNA-107 Targets IKBKG and Sensitizes A549 Cells to Parthenolide.
   Anticancer Res. 2018;38:6309-6316.
   PubMed     Text format     Abstract available
   
   
7. WU MF, Wang YC, Li HT, Chen WC, et al
   The Contribution of Interleukin-12 Genetic Variations to Taiwanese Lung Cancer.
   Anticancer Res. 2018;38:6321-6327.
   PubMed     Text format     Abstract available
   
   
8. AKAIKE K, Saruwatari K, Okabayashi H, Hamada S, et al
   Negative Impact of Coexisting Interstitial Lung Disease on Clinical Outcomes in Small-cell Lung Cancer Patients.
   Anticancer Res. 2018;38:6543-6550.
   PubMed     Text format     Abstract available
   
   

   
   BMC Cancer

9. KIM EJ, Ock M, Kim KP, Jung NH, et al
   Disease severity-based evaluation of utility weights for lung cancer-related health states in Korea.
   BMC Cancer. 2018;18:1081.
   PubMed     Text format     Abstract available
   
   
10. WANG X, Yin C, Su S, Li X, et al
    Long-term effects of neoadjuvant radiotherapy, adjuvant radiotherapy, and chemotherapy-only on survival of locally advanced non-small cell lung Cancer undergoing surgery: a propensity-matched analysis.
    BMC Cancer. 2018;18:1067.
    PubMed     Text format     Abstract available
    
    

    
    Br J Cancer

11. TIBALDI C, Camerini A, Tiseo M, Mazzoni F, et al
    Cytidine deaminase enzymatic activity is a prognostic biomarker in gemcitabine/platinum-treated advanced non-small-cell lung cancer: a prospective validation study.
    Br J Cancer. 2018 Nov 8. pii: 10.1038/s41416-018-0307.
    PubMed     Text format     Abstract available
    
    

    
    Cancer Lett

12. JUNG PY, Ryu H, Rhee KJ, Hwang S, et al
    Adipose tissue-derived mesenchymal stem cells cultured at high density express IFN-beta and TRAIL and suppress the growth of H460 human lung cancer cells.
    Cancer Lett. 2019;440-441:202-210.
    PubMed     Text format     Abstract available
    
    
13. ZHANG P, Kang B, Xie G, Li S, et al
    Genomic sequencing and editing revealed the GRM8 signaling pathway as potential therapeutic targets of squamous cell lung cancer.
    Cancer Lett. 2018;442:53-67.
    PubMed     Text format     Abstract available
    
    

    
    Cancer Res

14. HUA KT, Hong JB, Sheen YS, Huang HY, et al
    MicroRNA-519d promotes melanoma progression by downregulating EphA4.
    Cancer Res. 2017 Nov 1. pii: canres.1933.2017.
    PubMed     Text format     Abstract available
    
    
15. WANG J, Wang D, Niu X, Wang Z, et al
    Multiregion sequencing reveals the genetic heterogeneity and evolutionary history of osteosarcoma and matched pulmonary metastases.
    Cancer Res. 2018 Nov 2. pii: 0008-5472.CAN-18-1086.
    PubMed     Text format     Abstract available
    
    
16. ARNST KE, Wang Y, Hwang DJ, Xue Y, et al
    A Potent, Metabolically Stable Tubulin Inhibitor Targets the Colchicine Binding Site and Overcomes Taxane Resistance.
    Cancer Res. 2018;78:265-277.
    PubMed     Text format     Abstract available
    
    

    
    Cancer Sci

17. WATANABE S, Hayashi H, Haratani K, Shimizu S, et al
    Mutational activation of the EGFR down-regulates MHC class I expression via the ERK in non-small cell lung cancer.
    Cancer Sci. 2018 Nov 3. doi: 10.1111/cas.13860.
    PubMed     Text format     Abstract available
    
    
18. NIU L, Song X, Wang N, Xue L, et al
    Tumor-derived exosomal proteins as diagnostic biomarkers in non-small cell lung cancer.
    Cancer Sci. 2018 Nov 8. doi: 10.1111/cas.13862.
    PubMed     Text format     Abstract available
    
    

    
    Chest

19. NAVANI N, Fisher D, Tierney JF, Stephens RJ, et al
    The accuracy of clinical staging of stage I-IIIa non-small cell lung cancer: An analysis based on individual participant data.
    Chest. 2018 Oct 26. pii: S0012-3692(18)32607-2. doi: 10.1016/j.chest.2018.
    PubMed     Text format     Abstract available
    
    

    
    Clin Lung Cancer

20. SEYMOUR L, Le Teuff G, Brambilla E, Shepherd FA, et al
    LACE-Bio: Validation of Predictive and/or Prognostic Immunohistochemistry/Histochemistry-based Biomarkers in Resected Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2018 Oct 11. pii: S1525-7304(18)30262.
    PubMed     Text format     Abstract available
    
    
21. KIM EK, Kim KA, Lee CY, Kim S, et al
    Molecular Diagnostic Assays and Clinicopathologic Implications of MET Exon 14 Skipping Mutation in Non-small-cell Lung Cancer.
    Clin Lung Cancer. 2018 Oct 11. pii: S1525-7304(18)30265.
    PubMed     Text format     Abstract available
    
    

    
    Clin Nucl Med

22. PEREZ PM, Hope TA, Behr SC, van Zante A, et al
    Intertumoral Heterogeneity of 18F-FDG and 68Ga-PSMA Uptake in Prostate Cancer Pulmonary Metastases.
    Clin Nucl Med. 2018 Nov 3. doi: 10.1097/RLU.0000000000002367.
    PubMed     Text format     Abstract available
    
    

    
    Hum Pathol

23. VIDARSDOTTIR H, Tran L, Nodin B, Jirstrom K, et al
    Immunohistochemical profiles in primary lung cancers and epithelial pulmonary metastases.
    Hum Pathol. 2018 Oct 30. pii: S0046-8177(18)30396.
    PubMed     Text format     Abstract available
    
    

    
    Int J Cancer

24. CAI MC, Chen M, Ma P, Wu J, et al
    Clinicopathological, microenvironmental and genetic determinants of molecular subtypes in KEAP1/NRF2-mutant lung cancer.
    Int J Cancer. 2018 Nov 8. doi: 10.1002/ijc.31975.
    PubMed     Text format     Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

25. SIO TT, Atherton PJ, Pederson LD, Zhen WK, et al
    Daily Lisinopril vs Placebo for Prevention of Chemoradiation-Induced Pulmonary Distress in Patients With Lung Cancer (Alliance MC1221): A Pilot Double-Blind Randomized Trial.
    Int J Radiat Oncol Biol Phys. 2018 Nov 2. pii: S0360-3016(18)33924.
    PubMed     Text format     Abstract available
    
    

    
    J Cancer Res Clin Oncol

26. ZOU SM, Li WH, Wang WM, Li WB, et al
    The gene mutational discrepancies between primary and paired metastatic colorectal carcinoma detected by next-generation sequencing.
    J Cancer Res Clin Oncol. 2018;144:2149-2159.
    PubMed     Text format     Abstract available
    
    

    
    J Nucl Med

27. ZHUANG M, Vallez Garcia D, Kramer GM, Frings V, et al
    Variability and repeatability of quantitative uptake metrics in [(18)F]FDG PET/CT imaging of non-small cell lung cancer: impact of segmentation method, uptake interval, and reconstruction protocol.
    J Nucl Med. 2018 Nov 2. pii: jnumed.118.216028. doi: 10.2967/jnumed.118.216028.
    PubMed     Text format     Abstract available
    
    

    
    J Surg Oncol

28. MARGONIS GA, Buettner S, Andreatos N, Wagner D, et al
    The prognosis of colorectal cancer liver metastases associated with inflammatory bowel disease: An exploratory analysis.
    J Surg Oncol. 2018 Sep 27. doi: 10.1002/jso.25251.
    PubMed     Text format     Abstract available
    
    
29. KADEER X, Wang L, Zhang L, Shi W, et al
    Modified hook-wire placement technique for localizing multiple pulmonary nodules.
    J Surg Oncol. 2018;118:1188-1193.
    PubMed     Text format     Abstract available
    
    
30. VITI A, Socci L, Congregado M, Ismail M, et al
    The everlasting issue of prolonged air leaks after lobectomy for non-small cell lung cancer: A data-driven prevention planning model in the era of minimally invasive approaches.
    J Surg Oncol. 2018 Nov 6. doi: 10.1002/jso.25289.
    PubMed     Text format     Abstract available
    
    

    
    J Thorac Cardiovasc Surg

31. WANG Y, Yeung JC, Hanna WC, Allison F, et al
    Metachronous or synchronous primary lung cancer in the era of computed tomography surveillance.
    J Thorac Cardiovasc Surg. 2018 Oct 6. pii: S0022-5223(18)32556.
    PubMed     Text format     Abstract available
    
    
32. BRUNELLI A
    The timing of chemotherapy in multimodality treatment of locally advanced lung cancer: One size does not fit all.
    J Thorac Cardiovasc Surg. 2018 Oct 10. pii: S0022-5223(18)32609.
    PubMed     Text format    
    
    

    
    J Thorac Oncol

33. GELSOMINO F, Facchini G, Barbera MA, Lamberti G, et al
    Complete recalcification following arterial embolization of massive osteolytic bone metastasis from non-small cell lung cancer (NSCLC).
    J Thorac Oncol. 2018 Oct 31. pii: S1556-0864(18)33384.
    PubMed     Text format    
    
    
34. KIM Y, Lee B, Shim JH, Lee SH, et al
    Concurrent genetic alterations predict the progression to target therapy in EGFR-mutated advanced non-small cell lung cancer.
    J Thorac Oncol. 2018 Oct 31. pii: S1556-0864(18)33383.
    PubMed     Text format     Abstract available
    
    
35. BLAAUWGEERS H, Damhuis R, Lissenberg-Witte B, de Langen AJ, et al
    A population-based study of outcomes in surgically resected T3N0 non-small cell lung cancer in the Netherlands, defined using TNM-7 and TNM-8; justification of changes and an argument to incorporate histology in the staging algorithm?
    J Thorac Oncol. 2018 Nov 5. pii: S1556-0864(18)33413.
    PubMed     Text format     Abstract available
    
    
36. SINICROPI-YAO SL, Amann JM, Lopez DLY, Cerciello F, et al
    Co-expression analysis reveals mechanisms underlying the varied roles of NOTCH1 in non-small cell lung cancer.
    J Thorac Oncol. 2018 Nov 5. pii: S1556-0864(18)33411.
    PubMed     Text format     Abstract available
    
    
37. ZHANG C, Li SL, Nie Q, Dong S, et al
    Neoadjuvant Crizotinib in Resectable Locally Advanced Non-Small-Cell Lung Cancer with ALK-rearrangement: A Brief Report.
    J Thorac Oncol. 2018 Nov 5. pii: S1556-0864(18)33410.
    PubMed     Text format     Abstract available
    
    

    
    Lancet Oncol

38. SOLOMON BJ, Besse B, Bauer TM, Felip E, et al
    Lorlatinib in patients with ALK-positive non-small-cell lung cancer: results from a global phase 2 study.
    Lancet Oncol. 2018 Nov 6. pii: S1470-2045(18)30649.
    PubMed     Text format     Abstract available
    
    

    
    N Engl J Med

39. KWATRA SG, Stander S, Kang H
    PD-1 Blockade-Induced Pruritus Treated with a Mu-Opioid Receptor Antagonist.
    N Engl J Med. 2018;379:1578-1579.
    PubMed     Text format    
    
    

    
    Nat Med

40. FORMENTI SC, Rudqvist NP, Golden E, Cooper B, et al
    Radiotherapy induces responses of lung cancer to CTLA-4 blockade.
    Nat Med. 2018 Nov 5. pii: 10.1038/s41591-018-0232.
    PubMed     Text format     Abstract available
    
    

    
    Oncol Rep

41. CHEN M, Hu C, Guo Y, Jiang R, et al
    Ophiopogonin B suppresses the metastasis and angiogenesis of A549 cells in vitro and in vivo by inhibiting the EphA2/Akt signaling pathway.
    Oncol Rep. 2018;40:1339-1347.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

42. VELCHETI V, Patwardhan PD, Liu FX, Chen X, et al
    Real-world PD-L1 testing and distribution of PD-L1 tumor expression by immunohistochemistry assay type among patients with metastatic non-small cell lung cancer in the United States.
    PLoS One. 2018;13:e0206370.
    PubMed     Text format     Abstract available
    
    
43. ASHTON JR, Gottlin EB, Patz EF Jr, West JL, et al
    A comparative analysis of EGFR-targeting antibodies for gold nanoparticle CT imaging of lung cancer.
    PLoS One. 2018;13:e0206950.
    PubMed     Text format     Abstract available
    
    
44. JONES RA, Franks SE, Moorehead RA
    Comparative mRNA and miRNA transcriptome analysis of a mouse model of IGFIR-driven lung cancer.
    PLoS One. 2018;13:e0206948.
    PubMed     Text format     Abstract available
    
    
45. GEZELIUS E, Flou Kristensen A, Bendahl PO, Hisada Y, et al
    Coagulation biomarkers and prediction of venous thromboembolism and survival in small cell lung cancer: A sub-study of RASTEN - A randomized trial with low molecular weight heparin.
    PLoS One. 2018;13:e0207387.
    PubMed     Text format     Abstract available
    
    

    
    Proc Natl Acad Sci U S A

46. XIAO GY, Mohanakrishnan A, Schmid SL
    Role for ERK1/2-dependent activation of FCHSD2 in cancer cell-selective regulation of clathrin-mediated endocytosis.
    Proc Natl Acad Sci U S A. 2018;115:E9570-E9579.
    PubMed     Text format     Abstract available
    
    

    
    Semin Oncol

47. SAAVEDRA D, Neninger E, Rodriguez C, Viada C, et al
    CIMAvax-EGF: Toward long-term survival of advanced NSCLC.
    Semin Oncol. 2018;45.
    PubMed     Text format     Abstract available
    
    
48. MARUR S, Singh H, Mishra-Kalyani P, Larkins E, et al
    FDA analyses of survival in older adults with metastatic non-small cell lung cancer in controlled trials of PD-1/PD-L1 blocking antibodies.
    Semin Oncol. 2018 Oct 31. pii: S0093-7754(18)30157.
    PubMed     Text format     Abstract available
    
    

    
    Thorax

49. WOOLHOUSE I, Maskell NA
    Introducing the new BTS guideline: the investigation and management of pleural malignant mesothelioma.
    Thorax. 2018;73:210-212.
    PubMed     Text format    
    
    
50. LI R, Li X, Xue R, Yang F, et al
    Early metastasis detected in patients with multifocal pulmonary ground-glass opacities (GGOs).
    Thorax. 2018;73:290-292.
    PubMed     Text format    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: